Tempest Therapeutics (TPST) Net Shares Issued and Repurchased (2011 - 2015)
Tempest Therapeutics' (TPST) quarterly Net Shares Issued and Repurchased came in at $419500.0 in Q1 2015, up 11.24% year-over-year from $377098.0 in Q1 2014, and up 109.75% quarter-over-quarter from $200000.0 in Q4 2014.
Analysis
Tempest Therapeutics (TPST) Net Shares Issued and Repurchased (2011 - 2015) Analysis & Trends
Tempest Therapeutics has disclosed Net Shares Issued and Repurchased across 5 years of filings, most recently posting $419500.0 for Q1 2015.
- In Q1 2015, Net Shares Issued and Repurchased rose 11.24% year-over-year to $419500.0; the TTM figure through Mar 2015 stood at $419500.0 (up 11.24% YoY), while the FY2014 annual figure was $2.5 million, up 60.3% from the prior year.
- Net Shares Issued and Repurchased came in at $419500.0 for Q1 2015 at Tempest Therapeutics, up from $200000.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.5 million in Q4 2013 to a low of $60799.0 in Q1 2012.
- Average Net Shares Issued and Repurchased over 5 years is $395900.3, with a median of $358205.5 recorded in 2012.
- Year-over-year, Net Shares Issued and Repurchased soared 619.65% in 2013 and slumped 86.99% in 2014.
- Over 5 years, Net Shares Issued and Repurchased stood at $165339.0 in 2011, then surged by 105.22% to $339313.0 in 2012, then jumped by 353.02% to $1.5 million in 2013, then tumbled by 86.99% to $200000.0 in 2014, then soared by 109.75% to $419500.0 in 2015.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $419500.0 in Q1 2015, $200000.0 in Q4 2014, and $500000.0 in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 419,500.00 |
| Dec 31, 2014 | 200,000.00 |
| Sep 30, 2014 | 500,000.00 |
| Jun 30, 2014 | 500,000.00 |
| Mar 31, 2014 | 377,098.00 |
| Dec 31, 2013 | 1.54 Mn |
| Mar 31, 2013 | 437,542.00 |
| Dec 31, 2012 | 339,313.00 |
| Sep 30, 2012 | 141,000.00 |
| Jun 30, 2012 | 73,041.00 |
| Mar 31, 2012 | 60,799.00 |
| Dec 31, 2011 | 165,339.00 |